No Sci-Tech Innovation, No Future! Yangtze River Delta Jujin Sci-Tech Innovation Competition Concludes; EClinCloud Clinical Evidence Support Cloud Platform Wins Award

Source: EClinCloud.

Igniting the engine of development with the spark of science and technology
Answering the call of the times with the power of innovation
No sci-tech innovation, no future
This is a large-scale sci-tech innovation competition
and also a dialogue between sci-tech innovators, management scholars, and industry experts
empowering through management and sci-tech innovation
to infuse China's surging economy with unstoppable sci-tech innovation momentum
▼

On July 1, the 2023 Yangtze River Delta Jujin Sci-Tech Innovation Competition National Finals concluded successfully at Fudan University in Shanghai. Co-hosted by the Fudan University School of Management and the Shanghai Yangtze River Delta Business Innovation Institute by pooling high-quality domestic and international resources, the Yangtze River Delta Jujin Sci-Tech Innovation Competition is a professional competition for technology-based enterprises. It is dedicated to building an important platform for cultivating and connecting sci-tech enterprises, and to nurturing, incubating, and supporting the growth of innovative, cutting-edge, and breakthrough sci-tech projects.
As a technology company focused on clinical R&D, EClinCloud has consistently combined frontier technology with life data to build a globally leading "patient-centric" clinical evidence support SaaS cloud platform. Dr. Qin Long, founder and CEO of EClinCloud, entered this technology competition with EClinCloud's Clinical Evidence Support Cloud Platform project.
▼

▼

Focusing on key tracks including next-generation information technology, biomedicine, high-end manufacturing, new energy/new materials/energy conservation and environmental protection, and general technology sectors, the 2023 Yangtze River Delta Jujin Sci-Tech Innovation Competition spanned six months across four major competition regions—Jiangsu, Zhejiang, Shanghai, and Anhui. It attracted 253 project registrations. Through seven preliminary and semifinal rounds of rigorous screening, nearly 80 expert professors, investors, and sci-tech entrepreneurs participated in the review and exchange, and 156 teams advanced to the preliminary round.
▼





Swipe to view more
The Yangtze River Delta Jujin Sci-Tech Innovation Competition is more than just a contest;
EClinCloud is a technology company focused on clinical R&D, offering an integrated, interconnected all-in-one clinical trial cloud platform (including solutions such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis across technology products and offerings such as eCOA, CTMS, eTMF, EDC, RTSM, and RM) as well as clinical trial endpoint assessment technologies across therapeutic areas (including central nervous system, ophthalmology, and others). By combining cutting-edge technology with life sciences data to build a globally leading, "patient-centric" SaaS cloud platform for clinical evidence support, it helps domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate drug/device launches, and benefit countless patients.



